The therapeutic armamentarium for heart failure with preserved ejection fraction (HFpEF) remains notably constrained. A factor contributing to this problem could be the scarcity of in vitro models for ...
Microsoft Corporation (NASDAQ: MSFT) continues to be one of the best-performing companies in the technology sector and the broader market. MSFT stock is up more than 19% in 2025, and over 132% in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback